1. Home
  2. CSTL vs TWI Comparison

CSTL vs TWI Comparison

Compare CSTL & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$20.59

Market Cap

597.8M

Sector

Health Care

ML Signal

HOLD

Logo Titan International Inc. (DE)

TWI

Titan International Inc. (DE)

HOLD

Current Price

$7.55

Market Cap

494.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
TWI
Founded
2007
1890
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
597.8M
494.4M
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
CSTL
TWI
Price
$20.59
$7.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$45.50
$12.00
AVG Volume (30 Days)
294.1K
402.9K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$344,229,000.00
N/A
Revenue This Year
$2.42
$3.69
Revenue Next Year
$12.69
$4.85
P/E Ratio
N/A
N/A
Revenue Growth
3.66
N/A
52 Week Low
$14.59
$6.43
52 Week High
$44.28
$11.70

Technical Indicators

Market Signals
Indicator
CSTL
TWI
Relative Strength Index (RSI) 47.18 50.90
Support Level $19.51 $7.17
Resistance Level $22.18 $8.29
Average True Range (ATR) 0.86 0.33
MACD 0.09 0.03
Stochastic Oscillator 46.78 54.55

Price Performance

Historical Comparison
CSTL
TWI

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. It designs and manufactures products for OEMs and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. The company operates through three segments, namely Agricultural, Earthmoving/Construction, and Consumer. It derives the majority of revenue from the Agricultural segment which manufactures various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment. Geographically, the company generates the maximum revenue from North America, followed by Europe / CIS, Latin America, and Asia and other regions.

Share on Social Networks: